Swiss startup Luciole Medical announced today that it has closed a $5.5 million (CHF 5.3 million) Series A financing round to begin commercializing its minimally-invasive monitoring probe to measure blood oxygen levels in the brains of patients in intensive care units.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,